Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Updated on: August 27,2024 0

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Updated on:August 27,2024 0

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Updated on: August 27,2024 0

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Updated on:August 27,2024 0

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Updated on: August 27,2024 0

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Updated on:August 27,2024 0

Improving transplant success and single cell analysis revealing cell state changes in prostate cancer

byMemorial Sloan Kettering Cancer CenterAn MSK scientist works in the lab. Credit: Memorial Sloan Kettering Cancer CenterNew research from Memorial Sloan Kettering Cancer Center (MSK) showed giv

Updated on: August 27,2024 0

Improving transplant success and single cell analysis revealing cell state changes in prostate cancer

byMemorial Sloan Kettering Cancer CenterAn MSK scientist works in the lab. Credit: Memorial Sloan Kettering Cancer CenterNew research from Memorial Sloan Kettering Cancer Center (MSK) showed giv

Updated on:August 27,2024 0

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Updated on: August 27,2024 0

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Updated on:August 27,2024 0

AI bowel cancer test can tell whether patients need chemotherapy

byUniversity of LeedsCredit: Pixabay/CC0 Public DomainA new artificial intelligence (AI) test to determine the risk of bowel cancers coming back could help patients avoid chemotherapy, according

Updated on: August 27,2024 0

AI bowel cancer test can tell whether patients need chemotherapy

byUniversity of LeedsCredit: Pixabay/CC0 Public DomainA new artificial intelligence (AI) test to determine the risk of bowel cancers coming back could help patients avoid chemotherapy, according

Updated on:August 27,2024 0

Daily aspirin cuts odds for colon cancer: who benefits most?

by Ernie MundellIt's long been known that a daily dose of low-dose aspirin helps keepcolon cancerat bay.But new research suggests that those who benefit most are folks whose lifestyles

Updated on: August 27,2024 0

Daily aspirin cuts odds for colon cancer: who benefits most?

by Ernie MundellIt's long been known that a daily dose of low-dose aspirin helps keepcolon cancerat bay.But new research suggests that those who benefit most are folks whose lifestyles

Updated on:August 27,2024 0

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

byBaylor College of MedicineStimulation of serotonergic neurons suppresses EPN tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s41586-024-07751-zA study published inNature&nbs

Updated on: August 26,2024 0

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

byBaylor College of MedicineStimulation of serotonergic neurons suppresses EPN tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s41586-024-07751-zA study published inNature&nbs

Updated on:August 26,2024 0

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei

Updated on: August 26,2024 0

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei

Updated on:August 26,2024 0

Study explores how antifragility in complex dynamical systems could revolutionize cancer treatment

byH. Lee Moffitt Cancer Center & Research InstituteAntifragility-associated terms, defined for technical and natural (biological) systems. Credit:npj Complexity(2024). DOI: 10.10

Updated on: August 26,2024 0

Study explores how antifragility in complex dynamical systems could revolutionize cancer treatment

byH. Lee Moffitt Cancer Center & Research InstituteAntifragility-associated terms, defined for technical and natural (biological) systems. Credit:npj Complexity(2024). DOI: 10.10

Updated on:August 26,2024 0

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Updated on: August 26,2024 0

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Updated on:August 26,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024 0